Changes in serum albumin levels and neutrophil-lymphocyte ratio in patients with convulsive status epilepticus

dc.contributor.authorOzdemir, Hasan H.
dc.contributor.authorAkil, Esref
dc.contributor.authorAcar, Abdullah
dc.contributor.authorTamam, Yusuf
dc.contributor.authorVarol, Sefer
dc.contributor.authorCevik, Mehmet Ugur
dc.contributor.authorArikanoglu, Adalet
dc.date.accessioned2024-04-24T16:24:18Z
dc.date.available2024-04-24T16:24:18Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: Inflammation may be involved in the ictogenesis and development of some partial epilepsies. Serum albumin levels and the neutrophil-lymphocyte ratio (NLR) are markers of inflammation. The aim of this study was to investigate the ability of serum albumin levels and NLR to predict inflammation in patients with convulsive status epilepticus (CSE). Methods: This retrospective study was conducted on 58 patients who were diagnosed with CSE and control group comprised of 58 healthy individuals. Albumin levels and NLR were evaluated during both the acute and subacute periods of CSE. Results: The average serum albumin levels were 3.27 +/- 0.62 g/dL during the acute period and 3.4 +/- 0.67 g/dL in the subacute period in the patient group and 3.92 +/- 0.52 g/dL in the control group. Neutrophil counts were higher in patients in the acute phase of CSE, but lymphocyte counts were lower compared to the control group and the subacute phase. The average NLR values were 4.83 +/- 5.1 in the acute period, 3.07 +/- 3.02 during the subacute period and 1.98 +/- 0.42 in the control group. Serum albumin and NLR levels were significantly different between the patients in the subacute and acute periods of CSE and the control group (p < 0.05). There were significant negative correlational relationships between serum albumin and NLR levels (p < 0.05). Conclusion: We found serum albumin levels were significantly lower and the NLR was significantly higher in the acute period of CSE. Neutrophil-mediated inflammation may be important in the aetiopathogenesis of CSE.en_US
dc.identifier.doi10.1080/00207454.2016.1187606
dc.identifier.endpage420en_US
dc.identifier.issn0020-7454
dc.identifier.issn1563-5279
dc.identifier.issue5en_US
dc.identifier.pmid27161531
dc.identifier.scopus2-s2.0-84969771901
dc.identifier.scopusqualityQ2
dc.identifier.startpage417en_US
dc.identifier.urihttps://doi.org/10.1080/00207454.2016.1187606
dc.identifier.urihttps://hdl.handle.net/11468/16644
dc.identifier.volume127en_US
dc.identifier.wosWOS:000393988000006
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofInternational Journal of Neuroscience
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectConvulsive Status Epilepticusen_US
dc.subjectAlbuminen_US
dc.subjectNeutrophil-Lymphocyte Ratioen_US
dc.subjectInflammationen_US
dc.titleChanges in serum albumin levels and neutrophil-lymphocyte ratio in patients with convulsive status epilepticusen_US
dc.titleChanges in serum albumin levels and neutrophil-lymphocyte ratio in patients with convulsive status epilepticus
dc.typeArticleen_US

Dosyalar